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ABSTRACT
Genetic instability, provoked by exogenous muta-
gens, is well linked to initiation of cancer. However,
even in unstressed cells, DNA undergoes a plethora
of spontaneous alterations provoked by its inherent
chemical instability and the intracellular milieu. Base
excision repair (BER) is the major cellular pathway
responsible for repair of these lesions, and as defi-
ciency in BER activity results in DNA damage it has
been proposed that it may trigger the development
of sporadic cancers. Nevertheless, experimental ev-
idence for this model remains inconsistent and elu-
sive. Here, we performed a proteomic analysis of BER
deficient human cells using stable isotope labelling
with amino acids in cell culture (SILAC), and demon-
strate that BER deficiency, which induces genetic in-
stability, results in dramatic changes in gene expres-
sion, resembling changes found in many cancers.
We observed profound alterations in tissue home-
ostasis, serine biosynthesis, and one-carbon- and
amino acid metabolism, all of which have been iden-
tified as cancer cell ‘hallmarks’. For the first time,
this study describes gene expression changes char-
acteristic for cells deficient in repair of endogenous
DNA lesions by BER. These expression changes re-
semble those observed in cancer cells, suggesting
that genetically unstable BER deficient cells may be
a source of pre-cancerous cells.
INTRODUCTION
The molecular origin of all cancers lies in mutations in a
cell’s DNA sequence (1). Indeed, genomic instability and
mutation is recognised as one of the very few enabling char-
acteristics that clearly drive tumorigenesis by facilitating
the acquisition of all other core hallmarks of cancer (2).
Mutations can arise when the integrity of DNA is chal-
lenged by various agents deriving from exogenous sources
(3). To counteract the formation of mutations, cells have
evolved a plethora of DNA repair pathways that sense, re-
port and correct alterations in DNA (4). Deficiencies in
some of these repair pathways have been implicated to play
a key role in the induction and progression of cancer (5,6).
However, even without damage deriving from exogenous
sources (such as UV irradiation or tobacco smoke), DNA
is prone to spontaneous alterations caused by its chem-
ical instability and many different intracellular (endoge-
nous) mutagens (reviewed in (3)). It is estimated that every
single cell acquires as many as 10 000–20 000 lesions per
day under physiological and unstressed conditions (7). The
major cellular pathway to safeguard the genome against
these frequent and constantly arising DNA lesions is base
excision repair (BER), which is responsible for repairing
a multitude of different base alterations and DNA single
strand breaks (SSBs) (8). The importance of BER for cellu-
lar maintenance is exemplified by the fact that knocking out
any of the core BER pathway genes is embryonically lethal
(8). BER is initiated by damage-specific DNA glycosylases,
which identify and release the corrupted base by hydroly-
sis of the N-glycosylic bond linking the DNA base to the
sugar phosphate backbone (reviewed in (9)). In mammalian
cells, the arising abasic site (AP-site) is further processed
by AP-endonuclease 1 (APE1), which cleaves the phospho-
diester bond 5′ to the AP-site, generating a SSB with a
5′-sugar phosphate. Further processing of this intermedi-
ate is carried out by a DNA repair complex that includes
DNA polymerase  (Pol ), XRCC1 and DNA ligase IIIa
(Lig III). Pol  possesses a dRP- lyase activity that removes
the 5′-sugar phosphate and also, functioning as a DNA
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polymerase, adds one nucleotide to the 3′-end of the aris-
ing single-nucleotide gap. Finally, the XRCC1-Lig III com-
plex seals the DNA ends, therefore accomplishing DNA re-
pair (8). XRCC1 is a scaffold protein that is absolutely re-
quired for formation and stabilisation of the ternary Pol -
XRCC1-Lig III complex on SSBs arising spontaneously or
generated by APE1 during BER (10,11). Hence, cells defi-
cient in XRCC1 are characterised by reduced DNA repair
and genomic instability (reviewed in (12)).
While the role of faulty DNA double-strand break re-
pair in tumorigenesis is widely accepted, the role of other
DNA repair pathways, and in particular the contribution
of BER deficiency to cell transformation is far from being
understood. Given the importance of BER to cellular DNA
homeostasis, it is conceivable that a deficiency in this path-
way could contribute to carcinogenesis, or even initiate very
early steps of cellular transformation by acting as enabler
of carcinogenesis through induction of genomic instability
without the administration of exogenous damaging agents.
Indeed, knockdown of XRCC1 has been shown to cause a
deficiency in repair of DNA base damage and lead to an
accumulation of unrepaired SSBs (12). Furthermore, hap-
loinsufficiency in XRCC1 was found to sensitise mice to-
ward treatments with carcinogenic substances, resulting in
enhanced formation of precancerous lesions (13). Thus, we
hypothesised that a deficiency in BER and the following ac-
cumulation of unrepaired SSBs (that derive from endoge-
nous, spontaneously occurring DNA damage) would not
only lead to genetic instability and accumulation of muta-
tions, but also lead to specific changes in protein expression
as reaction to this permanent genetic instability. Moreover,
since genetically unstable cells have an increased probabil-
ity to become transformed, we predicted that this ‘imprint-
ing’ of changes on the proteomic level induced by genetic
instability might later be found in pre-malignant and trans-
formed cells, thus underscoring the role of BER deficiency
in tumorigenesis. To test this hypothesis, we performed a
proteomic analysis using stable isotope labelling of amino
acids in cell culture (SILAC) in primary human cells with a
BER deficiency brought about by knocking down XRCC1
using siRNA. Analysis of the most significant changes re-
vealed profound alterations in cellular serine biosynthesis,
the one-carbonmetabolism, amino acid uptake and synthe-
sis as well as regulation of cellular redox status. We also de-
tected significant changes in expression of proteins regulat-
ing tissue homeostasis, in particular proteins involved in cel-
lular motility, tissue remodelling and cellular invasion. All
these changes point to metabolic reprogramming as well as
alterations in tissue invasion and metastasis, each of which
is considered as a hallmark of cancer cells (2), suggesting
that these changes may originate from genetically unsta-
ble BER deficient cells. Additionally, by shedding light on
the role of BER deficiency in creating preconditions for cell
transformation, our observations also suggest that these ob-
served changes in metabolism and cellular motility are not
late-onset adaptations in full-blown cancerous cells, as is of-
ten assumed, but rather denote early adjustments to genetic
instability that can be found later in transformed cells.
MATERIALS AND METHODS
Cell culture
Human primary fibroblasts (TIG-1) were purchased from
Coriell and cultured under standard conditions in Dul-
becco’s modified Eagle’s medium (DMEM) (Invitrogen,
21885-108) supplemented with 15% Fetal Calf Serum
(FCS). For SILAC experiments, cells were grown in light
arginine/lysine (R0K0) or DMEM supplemented with
heavy arginine [13C6 Arg] and lysine [D4 Lys] (R6K4) la-
beled DMEM (Dundee cell products Ltd, LM014 and
LM016) and 15% dialysed FCS (molecular weight cut-off
3.5 K, Thermo Pierce) for a minimum of seven population
doublings to ensure optimal labeling efficiency.
Mass spectrometry
Cell fractionation for MS/MS analysis. Freshly harvested
cells were resuspended in two packed cell volumes of cold
buffer A (20 mM Tris pH 7.4, 2.5 mM MgCl2, 0.5%
(v/v) NP-40, 1 mM N-ethylmaleimide (NEM), 1 g/ml
Leupeptin, Pepstatin, Chymostatin, Aprotinin and Phenyl-
methanesulfonyl fluoride (PMSF)), vortexed to resuspend,
and incubated for 10min on ice.Nuclei were pelleted by cen-
trifugation of extracts at 10 000 rpm/10 621 rcf for 2 min.
The supernatant (cytoplasmic fraction) was transferred to
a fresh tube and stored on ice. The nuclear cell pellet was
then resuspended in buffer B (20 mM phosphate buffer pH
8.0, 500 mM NaCl, 1 mM EDTA, 0.75% (v/v) Triton X-
100, 10% glycerol, 5 mMMgCl2, 1 mM NEM, 1 g/ml le-
upeptin, pepstatin, chymostatin, aprotinin and PMSF) in
the same volume as used before for buffer A, vortexed to
resuspend, and incubated for 10 min on ice. Insoluble com-
ponents were then removed by spinning 2 min at 10 000
rpm/10 621 rcf, and the supernatant (nuclear fraction) was
transferred to a fresh tube. Protein samples were then re-
duced, alkylated and precipitated by chloroform/methanol
precipitation (14). The precipitate was resuspended in 6 M
urea in 100 mM Tris pH 7.4, digested with trypsin, de-
salted using C18 Sep Pak column cartridges and dried in
vacuo. Samples were resuspended in buffer A (98% H2O,
2% acetonitrile, 0.1% formic acid) and subjected to analy-
sis by nano- ultraperformance liquid chromatography tan-
demmass spectrometry nUPLC-MS/MS as described (14).
In brief, we used a nUPLC system (Water nAcquity) with
a 75 m x 250 mm, 1.7 m particle size) analysis coupled
to a Thermo LTQ Orbitrap Velos (60 000 resolution, Top
20, CID) workflow and a gradient of 1–40% acetonitrile
in 120 min at a flow rate of 250 nl/min. The analysis of
SILAC MS data was analysed using MaxQuant software
as described previously (15). Pathway analysis of the SILAC
data was generated through the use of IPA (Ingenuity R© Sys-
tems, www.ingenuity.com).
Western blotting and antibodies
Whole cell extracts for Western blotting were prepared
as described previously (16). Proteins were separated by
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) and transferred onto Immobilon-FL
Polyvinylidene fluoride (PVDF) membranes (Millipore)
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according to standard procedures (Novex). Blots were
probed with following antibodies: XRCC1 (Neomarkers,
MS-1393-P0), DNA polymerase  (raised in-house and
affinity-purified), -tubulin (Sigma, T6199), MCM4 (ab-
cam, ab4459-50), RP-A p32 (Bethyl, A300-244A), PCNA
(Santa Cruz, sc-56), -actin (Abcam, ab6276), PARP-1
(raised in-house and affinity-purified), p21 (Cell signaling,
12D1), PSAT1 (Novusbio, 21020002), PHGDH (Sigma,
HPA021241), p53 (Santa Cruz, sc-126), PNKP (Abnova,
H00011284-B01). Secondary antibodies conjugated with
Alexa Fluor 680 (Molecular Probes) and IRDye R© 800
(Rockland) fluorescent dyes were used. Detection and
quantificationwas carried out using anOdyssey image anal-
ysis system (Li-Cor Biosciences).
Knockdown by siRNA
Transfections with siRNA were carried out using Lipo-
fectamine RNAiMAX reagent (Invitrogen) according
to the manufacturer’s protocol. Cells were analysed at
indicated time-points after transfection. siRNA sequences
(Eurogentec) were as following: XRCC1 sequence 1:
5′-AGGGAAGAGGAAGUUGGAU-3′, XRCC1 se-
quence no. 2: 5′-GGAAGAUAUAGACAUUGAG-3′,
PNKP: 5′-CACACUGUAUUUGGUCAAU-3′, TDP1:
5′-CUAGACAGUUUCAAAGUG-3′ (17), ATF4 siRNA
(pool of 4 siRNAs, Dharmacon) was a kind gift fromChris-
tos Zois and Adrian Harris (Oxford). Control transfections
were carried out without addition of siRNA.
Quantitative RT-PCR
Total RNA was purified using the RNeasy kit (Qiagen)
and cDNA was prepared using the SuperScript RT-PCR
system (Invitrogen). Quantitative RT-PCR was performed
using Absolute Blue QPCR SYBR low ROXMix (Thermo
Scientific) according to the manufacturer’s protocol.
Reactions were carried out in duplicate for each target
transcript using a 7500 Fast Real-Time PCR System
(Applied Biosystems). The comparative CT method was
applied for quantification of gene expression, and values
were normalised against Glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) as control. Results were expressed as
fold change in mRNA levels. Following primers were used:
PHGDH for (5′-ATCTCTCACGGGGGTTGTG-3′),
PHGDH rev (5′-AGGCTCGCATCAGTGTCC3′), PSAT1
for (5′-CGGTCCTGGAATACAAGGTG3′), PSAT1 rev
(5′- AACCAAGCCCATGACGTAGA-3′), ATF4 for
(5′-GGGACAGATTGGATGTTGGAGA-3′), ATF4 rev
(5′-ACCCAACAGGGCATCCAAGT-3′), MTHFD2
for (5′-TGCTGCAGGTATTCCAAATC-3′), MTHFD2
rev (5′-GGGTTTGGCAGTTACAGGAT-3′), ATF4 for
(5′-GGGACAGATTGGATGTTGGAGA-3′), ATF4
rev (5′-ACCCAACAGGGCATCCAAGT-3′), GAPDH
for (5′-AGCCACATCGCTCAGACAC-3′), GAPDH
rev (5′-GCCCAATACGACCAAATCC-3′), TDP1 for
(5′-ATGGTGATAAGCGAGAGGCT-3′), TDP1 rev
(5′-CGGAGGCCTTCTTCATAGAG-3′).
G1 arrest
Cells were grown until confluence, after which KD was per-
formed with siRNA as usual.
Intracellular GSH measurement
Measurement of GSH levels in living cells was performed
after (18). In short, cells were seeded into 24-well plates at
the indicated densities 48 h after KD. Twenty four hours
later intracellular GSH was labeled by Dibromobimane,
which is fluorescently activated upon conjugation with thiol
groups. The signal was normalized to the cell density as as-
sessed by Hoechst 33342 staining. Fluorescent intensities
were read with a plate reader (EnVision, Perkin Elmer).
Graphical display of results and statistical analysis
For all statistical analysis and graphical display, the pro-
gram GraphPad Prism (www.graphpad.com) was used.
Flow cytometry
For FACS, trypsinized cells were fixed in ice-cold 70%
ethanol for at least 30 min. After removal of the fixation so-
lution by centrifugation, cells were treated with 100 g/ml
of DNase free RNase A at 37oC in phosphate buffered
saline for 30min (Sigma) and further stained with 10g/ml
propidium iodide (Sigma). Samples were run on a Becton–
DickinsonFACScan (BDBiosciences) and the cell cycle dis-
tribution analysed using Modfit LT software (Verity Soft-
ware House).
Alkaline comet assay
The comet assay was performed as recently described (10).
Briefly, cells were harvested by trypsinisation, diluted to a
concentration of 2 × 105 cells/ml in medium, and embed-
ded on a microscope slide in 1% low-melting agarose in
phosphate buffered saline (PBS) (Bio-Rad). The slides were
lysed in buffer containing 2.5 MNaCl, 100 mM ethylenedi-
aminetetraacetic acid (EDTA), 10 mM Tris–HCl pH 10.5,
1% (v/v) Dimethyl sulfoxide (DMSO) and 1% (v/v) Triton
X-100 for 1 h at 4◦C. Subsequently, the slides were then
incubated in the dark for 30 min in cold electrophoresis
buffer (300 mM NaOH, 1 mM EDTA, 1% (v/v) DMSO,
pH >13) to allow DNA unwinding prior to electrophoresis
at 25 V, 300 mA for 25 min. Neutralisation of the slides was
performed with 0.5 M Tris–HCl (pH 8.0). The slides were
stained with SYBR Gold (Invitrogen) and analysed using
the Komet 5.5 image analysis software (Andor Technology,
Belfast, Northern Ireland).
RESULTS
Outline of experimental approach
To perform quantitative SILAC analysis, primary human
BER deficient or control cells were cultured inDMEMwith
light R0K0 or medium R6K4 labeled isotopes, respectively
(Figure 1A). A deficiency in BER was brought about by
knocking down (KD) the BER scaffold protein XRCC1 by
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Figure 1. Outline and validation of the experimental approach. (A) Workflow scheme for the SILAC analysis. siRNA-mediated knockdown of XRCC1
or control was performed with Tig-1 cells grown in light (R0K0) or medium (R6K4) containing DMEM for 72 hours. Cells were harvested, mixed at a
ratio 1:1 and fractionated into cytoplasmic and nuclear fractions. Precipitated proteins were digested with trypsin and analyzed via liquid chromatography
MS/MS to quantify differences in peptide abundance. Results were further analyzed using the Ingenuity Pathway Analysis (IPA). (B) Western blot analysis
of the XRCC1 levels in WCE made from cells used in (A). -tubulin was used as loading control. (C) Representative Comets for Alkaline Comet assay
of siXRCC1 and control cells. Scale bar = 50 m. (D) Quantification of three independent Alkaline Comet assay experiments. Values are mean ± SD.
The P-value was calculated using Student’s two-tailed t-test. (E and F) Venn diagrams showing all detected proteins (E) or proteins up- or downregulated
≥2-fold (F) upon XRCC1 KD, as detected by IPA.
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siRNA transfection. Seventy-two hours after knockdown
cells were harvested, and a fraction was set aside to pre-
pare whole cell extracts (WCE) for validation purposes. The
remaining cells were combined at a 1:1 ratio and, in or-
der to increase the resolution for enhanced detection of
peptides by MS/MS analysis, fractionated into cytoplas-
mic and nuclear fractions. Thereafter, cellular proteins were
extracted, digested with trypsin, desalted and subjected to
analysis by quantitative mass spectrometry (MS/MS). MS
Data were extracted, and protein identification and SILAC
based quantitation were performed using the MS/MS and
MS data sets, respectively (see ‘Material and Methods’ sec-
tion). Relative quantitation reflecting changes in protein
abundance ratio are summarized in Supplementary Table
S2.
XRCC1 knockdown leads to DNA damage accumulation and
dysregulation of gene expression
To verify the KD efficiency of XRCC1, we performed west-
ern blot analysis on WCE (Figure 1B). We observed a de-
crease of about 80% in XRCC1 expression. Importantly,
a similar decrease in XRCC1 levels was also observed in
the SILAC dataset from the MS/MS analysis (2.7-fold de-
crease, Table 2, and Supplementary Table S2). The accumu-
lation of SSBs after XRCC1 knockdown depends on spon-
taneous formation of DNA base lesions. During attempted
repair some of these lesions are converted into SSBs due to
the deficiency in DNA gap-filling (by Pol ) and ligation
(by DNA ligase III). This means that the rate-limiting step
is accumulation of endogenous lesions, which is followed by
SSB accumulation. As we have recently demonstrated (16)
that significant accumulation of DNA single strand breaks
is achieved at 72 h after XRCC1 siRNAapplication, we thus
chose this time-point for further investigation. The partial
deficiency in DNA repair caused by XRCC1 KD resulted
in the persistent accumulation of unrepaired endogenous
DNA lesions at 72 h after KD of XRCC1, as measured by
the alkaline Comet assay which detects DNA strand breaks
and alkaline labile base lesions (Figure 1C and D) (19). Of
note, the extent of XRCC1 KD does not completely abro-
gate the ability to repair SSBs, but decreased the BER ca-
pacity, which led to a marked delay in, but not a complete
absence of SSB repair (20).
A total of 2885 proteins were identified in the sample
by mass spectrometry, of which 643 were uniquely found
in the cytoplasmic, and 869 uniquely in the nuclear frac-
tion, respectively (Figure 1E and Supplementary Table S2).
1373 proteins were identified in both fractions. Applying
a cutoff value of a minimum 2-fold change in abundance
upon XRCC1KD revealed 242 proteins significantly up- or
downregulated, 104 of which were in the cytoplasm, 117 in
the nucleus and 21 proteins present in both fractions (Fig-
ure 1F).
XRCC1 knockdown activates the G1/S checkpoint
Further analysis of the peptides identified by MS/MS was
performed using the Ingenuity pathway analysis (IPA) soft-
ware, which allows the identification and ranking of dereg-
ulated pathways in a specific dataset by extrapolating from
to changes in abundance of individual proteins involved
in these pathways. Using this method, by combining pro-
teomic data from both the nuclear and cytoplasmic frac-
tions in a so-called combined heatmap analysis, a list of
most deregulated (up- or downregulated) pathways from
the entire dataset was obtained, of which we decided to look
closer at the top 17 deregulated pathways (Table 1).
As primary cells harbor intact DNA damage signal-
ing pathways, the accumulating DNA damage caused by
XRCC1 KD was expected to induce a DNA damage-
dependent checkpoint of the cell cycle. Indeed, pathway
analysis of the proteomic data by IPA combined heatmap
analysis identified an activation of the G1/S DNA dam-
age checkpoint, which was highly ranked among the most
significantly deregulated pathways in the dataset (Table 1,
rank 2). In accordance with this, we observed the induc-
tion of the known G1 arrest mediators CDKN1A/p16, and
CDKN2A/p21, in the MS/MS data (albeit with an induc-
tion<2-fold, Table 2). Up-regulation of p21 was confirmed
by western blot analysis (Figure 2A and B). Though the
G1/S arrest is known to be regulated by p53, we did not
observe a change in p53 protein levels upon XRCC1 KD,
suggesting that it was activated rather by posttranslational
modifications than MDM2 inhibition (Figure 2A). Delay
of DNA replication and accumulation of cells in G1 phase
of the cell cycle were further verified by FACS analysis (Fig-
ure 2C). Importantly, however, despite the accumulation of
cells in G1, these cells were still cycling, as evidenced by the
fraction of cells in S andG2 phases, suggesting that accumu-
lating SSBs caused by a decrease in the BER capacity induce
a transient G1 delay to repair the damage before entering S-
phase. Additionally, the transient accumulation of cells in
G1 due toDNAdamage led to a clear downregulation of the
subunits of the replicative DNA helicase MCM2–7, Orc5 (a
member of the origin recognition complex proteins), RPA
subunit 1 (an important DNA-binding factor at replication
forks), PCNA (the ring-shaped molecule that coordinates
replication proteins at the replication fork), and RFC sub-
unit 1 (responsible for loading PCNA onto the fork) (Ta-
ble 2 and Figure 2D and E). Taken together, these data
confirmed that the XRCC1 knockdown led to accumula-
tion of DNA lesions, which resulted in a DNA damage-
dependent G1/S checkpoint activation. The decrease in S-
phase cells also explains, whyDNA repair pathways flagged
up as significantly changed among the other pathways (Ta-
ble 1, ranks 9 and 10, and Table 2, light red). Most of these
proteins that play a role in DNA repair are also strongly as-
sociatedwithDNAreplication (RPA, PCNA,RFC). There-
fore, in our dataset, we interpret changes in these DNA re-
pair pathways to be mainly a secondary effect deriving from
the G1/S-arrest.
Detailed analysis of the top regulated pathways and proteins
For a detailed assessment of a possible link of BER to
pre-malignant cellular transformation, we further analysed
the 17 top deregulated pathways obtained by combined
heatmap analysis using IPA (see above) (Table 1). Despite
a wide diversity of these top pathways at first glance, a
high amount of overlapping protein components could be
identified between many of them. For example, alpha-2-
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Table 1. The top regulated pathways upon XRCC1 knockdown
P P
A combined heatmap analysis for all regulated proteins in both fractions was performed using IPA. Shown are the deregulated pathway’s rank number
resulting from the heatmap analysis, the name of the canonical pathway affected, as well as the –log(P) value in each of the fractions. Pathways were further
grouped into four categories, according to the deregulated proteins that were detected for each of them. Pathways with white background are all associated
with tissue remodeling, light brown denotes cell cycle control, light blue indicates one-carbon metabolism and DNA repair is colored light red.
Table 2. Proteins associated with cell cycle control and DNA repair that are deregulated upon XRCC1 knockdown
List of proteins detected by SILAC associated with the cell cycle control pathway (light blue) or DNA repair (light red). Given are the gene symbol and
the Entrez gene name of the target, as well as the fold change in the nuclear and cytoplasmic fractions, respectively. Positive values indicate upregulation,
whereas negative values denote proteins downregulated upon XRCC1 KD. Proteins downregulated ≥2-fold are shown in green. The last column specifies
which of the pathways from Table 1 the targets are associated with. When no pathway number is given, the targets were added after manually searching
the dataset. n.d. = not detected.
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Figure 2. XRCC1 knockdown activates a DNA damage response and delays cell cycle progression. (A and D) Western blot analysis of the indicated
proteins upon XRCC1KD. -Tubulin served as a loading control. (B) Quantifications of p21 protein levels as seen in (A). Values are mean± SD from four
independent experiments, normalized to the loading control. The P-value was calculated using Student’s t-test. (C) FACS analysis of cell-cycle distribution
after XRCC1 KD. Shown is the percentage of cells in the respective cell cycle phases after control treatment or XRCC1 KD. Values are mean ± SD from
three independent experiments. The P-value was calculated using Student’s two-tailed t-test. (E) Quantification of protein levels as seen in (D). Values are
mean ± SD from four independent experiments, normalized to the loading control. The P-value was calculated using Student’s t-test.
macroglobulin (A2M) is attributed to pathways no. 1, 4 and
16 (Table 3, last column), whereas matrix metallopeptidase
2 (MMP2) is associated with pathways no. 1, 4, 7, 14 and
17 (Table 3, last column). Taking into account these redun-
dancies in detected targets, these top 17 pathways could be
further grouped into four distinct categories summarized in
Table 1: tissue remodeling (white), cell cycle control (light
brown), one-carbon metabolism (light blue), and DNA re-
pair (light red). To further understand the changes, these
categories were analysed in detail as discussed below (except
for the cell cycle control pathway, as discussed above). Fur-
thermore, other proteins that are closely related to these top
17 pathways, which however did not score among the top
17 pathways, but displayed significant changes (i.e. changes
≥2-fold up or down), were manually included in Table 3 to
enhance the picture of the global changes in these cells.
XRCC1 KD induces changes in the one-carbon metabolism,
energy metabolism and amino acid synthesis and uptake
Metabolic reprogramming of cancer cells was first proposed
by Otto Warburg (reviewed (21)), and is one of the hall-
marks of cancer (2). One of the central metabolic pathways
for cellular homeostasis is one-carbon metabolism, which
encompasses the serine biosynthesis pathway, and, over the
last few years, has come to be recognized to play a pivotal
role in tumorigenesis (22). Because of its importance for
cellular metabolism, we were highly intrigued by the fact
that the one carbon metabolism scored among the most
significantly deregulated pathways in our heatmap analy-
sis (Table 1, blue). More specifically, XRCC1 KD cells dis-
played a significant increase in the three key enzymes in-
volved in serine biosynthesis, PHGDH, PSAT1 and PSPH
(Table 3, blue). The upregulation of PSAT1 and PHGDH
upon XRCC1 KD was further validated by western blot
as well as on mRNA level by qPCR (Figure 3A–C), and
with a second siRNA sequence against XRCC1 (Supple-
mentary Figure S1). Transcription of PHGDH, PSAT1
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Table 3. Proteins associated with tissue remodeling, one-carbon metabolism, cellular redox reactions, amino acid transporters and the mitochondrial
respiratory chain that are deregulated upon XRCC1 knockdown
List of proteins associated with the tissue remodeling pathways (white), the serine biosynthesis pathway and one-carbon metabolism (light blue), cellular
antioxidant functions (light purple), amino acid uptake (light red), and the mitochondrial energy metabolism (light green). Given are the gene symbol and
the Entrez gene name of the target, as well as the fold change in the nuclear and cytoplasmic fractions, respectively. Positive values indicate upregulation,
whereas negative values denote proteins downregulated upon XRCC1 KD. Proteins upregulated ≥2-fold are shown in red, and proteins downregulated
≥2-fold are shown in green. The last column specifies which of the pathways from Table 1 the targets are associated with. When no pathway number is
given, the targets were added after manually searching the dataset. n.d. = not detected.
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Figure 3. XRCC1 knockdown induces changes in proteins associated with serine biosynthesis, the one-carbon metabolism and cellular redox functions.
(A) Western blot analysis of PHGDH and PSAT1 upon XRCC1 KD. -Tubulin served as a loading control. (B) Quantifications of protein levels as seen in
(A). Values are mean± SD from eight independent experiments, normalized to the loading control. The P-values were calculated using Student’s t-test. (C)
mRNA levels of PHGDH and PSAT1 after XRCC1 KD, quantified by qPCR and normalized to GAPDH. Values are mean ± SD from 10 independent
experiments. The P-values were calculated using Student’s t-test. (D) mRNA levels of ATF4 after XRCC1 KD, quantified by qPCR and normalized to
GAPDH. Values are mean ± SD from three independent experiments. The P-value was calculated using Student’s t-test. (E) Western blot analysis of
PHGDH and PSAT1 upon KD of ATF4, XRCC1 or both. -Actin served as a loading control. (F) mRNA levels of ATF4 and PSAT1 after KD of ATF4,
XRCC1, or both, quantified by qPCR and normalized to GAPDH. Values are mean ± SD from two independent experiments. (G) Western blot analysis
of PHGDH and PSAT1 upon KD of XRCC1 in G1 arrested cells. -Tubulin served as a loading control.
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and PSPH has been shown to be regulated by ATF4 (23).
ATF4 is a transcription factor that induces the expression
of a variety of anabolic genes involved in nutrient uptake,
amino acid metabolism, and anti-oxidation in response to
a variety of different stresses, in a process termed integra-
tive stress response (ISR) (24). Consistent with this, we
found an increase in ATF4 mRNA after XRCC1 KD, sug-
gesting the activation of the ISR upon XRCC1 KD (Fig-
ure 3D). This was validated with a second siRNA sequence
against XRCC1 (Supplementary Figure S1E). To verify
the causal role of ATF4 in the upregulation of the one-
serine metabolism upon XRCC1 KD, we performed a com-
bined KD of ATF4 and XRCC1. Indeed, KD of ATF4
completely abrogated the XRCC1-KD mediated upregu-
lation of PSAT1 and PHGDH on protein as well as on
mRNA levels (Figure 3E and F). To exclude that the ob-
served upregulation of the enzymes involved in one-carbon
metabolism was merely a result of the G1 arrest, we per-
formed a KD of XRCC1 in G1 arrested cells. Similarly to
the non-synchronized cells, KD of XRCC1 in G1 arrested
cells also led to an increase of PSAT1 and PHGDH, rul-
ing out an indirect cell-cycle mediated effect (Figure 3G).
To demonstrate that the observed changes in gene expres-
sion of PSAT1 and PHGDH are due to accumulation of
DNA SSBs and are not caused by some side effects of
XRCC1KD, we investigated the effect of PNKP and TDP1
knockdown on the expression of PSAT1 and PHGDH.
Both PNKP and TDP1 are required for processing of dam-
aged DNA strand breaks and a deficiency in either of these
proteins leads to accumulation of SSBs (25). We found
that, similar to XRCC1 knockdown, KD of either PNKP
or TDP1 lead to an increased expression of both PSAT1
and PHGDH (Figure 4A–C). Importantly, XRCC1 levels
did not changed after either PNKP or TDP1 knockdown.
These results clearly demonstrated that the observed upreg-
ulation of the one-carbon metabolism upon accumulation
of persistent DNA single strand breaks is activated by BER
deficiency and is due to an activation of the integrated stress
response pathway governed by ATF4.
The serine biosynthesis pathway (Supplementary Figure
S2) provides direct inputs into the one-carbon metabolism,
which consists of the folate and the methionine cycles, as
well as the transsulfuration pathway. By donating a car-
bon unit from its side chain to tetrahydrofolate, serine feeds
directly into the folate cycle. The folate cycle can provide
building blocks for nucleotide synthesis, and additionally
fuels themethionine cycle and the transsulfuration pathway.
As a ‘side product’ of the carbon donation step, serine itself
is converted to glycine, which in turn can again directly feed
the folate cycle. Interestingly, the tetrahydrofolate salvage
pathway involving the enzyme MTHFD2 was significantly
upregulated upon XRCC1 KD both on protein (Table 1,
rank 12) andmRNA levels (Figure 5A), suggesting that this
metabolic branch is indeed in a state of enhanced activity.
This was verified with a second siRNA sequence against
XRCC1 (Supplementary Figure S1). Of note, ATF4−/- cells
have been found to display decreased levels of MTHFD2
(24), suggesting that MTHFD2 up-regulation in XRCC1
KD cells may be a consequence of increased ATF4 expres-
sion observed in our experiments (Figure 3D). In addition
to the increase in intracellular synthesis of amino acids by
the serine biosynthesis pathway, we also observed an in-
crease in expression of a variety of amino acid transporters
of the solute carrier family (Table 3, light red). Interest-
ingly, SLC1A4, SLC3A2, SLC7A1 and SLC7A5 are all reg-
ulated by ATF4 as well (24,26). These changes further sup-
port the notion that XRCC1 KD promotes changes in cel-
lular metabolism toward an anabolic state via the ATF4-
mediated ISR pathway.
One of the outputs of serine metabolism is to con-
tribute to the biosynthesis of glutathione (GSH), a ma-
jor cellular antioxidant, which can scavenge reactive oxy-
gen species and contribute to the maintenance of the ap-
propriate NADPH/NADP+ ratios for cellular metabolism.
GSH is a tripeptide, consisting of cysteine, glycine and glu-
tamate. By condensing with homocysteine from the me-
thionine cycle, serine is converted to GSH via interme-
diate steps by the transsulfuration pathway (22). Consis-
tent with an activation of the one-carbon metabolism, and
specifically also the transsulfuration pathway, we observed
a clear increase in intracellular GSH levels upon XRCC1
KD (Figure 5B). Interestingly, enzymes involved in antiox-
idant functions (such as glutathione peroxidase 1, micro-
somal glutathione S-transferase 2, FOS-like antigen 1 and
heme oxygenase (decycling) 1) were also differentially regu-
lated upon XRCC1 KD (Table 3, light purple), suggesting
the activation of a cellular redox-stress response.
In summary, these findings imply that cells with persistent
SSBs activate a stress-response involving serine biosynthesis
and the one-carbon metabolism, as well as amino acid up-
take, thus instituting a change toward an anabolic cellular
state by enhancing their amino acid synthesis as well as an
increased antioxidant capacity via the production of GSH.
Energy metabolism
A recently proposed concept by Maddocks et al. suggested
that an increased activity in the serine biosynthesis path-
way in cancer cells leads to a decrease in pyruvate levels due
to the metabolic rerouting of glycolytic intermediates (27).
To compensate for the resulting decrease in pyruvate lev-
els, cells preferentially metabolised the remaining pyruvate
via the more energy-efficient TCA cycle, in order to gener-
ate sufficient amounts of ATP for cellular transactions via
mitochondrial respiration. In agreement with this idea, our
data showed a clear increase in various components of the
mitochondrial respiratory chain, including ATP synthase
coupling factor 6, carnitine palmitoyltransferase 1A, and
NADH dehydrogenase Fe–S proteins 1 and 3 (Table 3, light
green).
XRCC1 knockdown leads to increased expression of genes
linked to excessive tissue remodelling, cellular motility and
invasiveness
The classical clinical presentation of a cancer as a ‘lump’
can be attributed to the so-called ‘desmoplastic reaction’
of tumor and surrounding tissue, which is characterised
by an excessive deposition of collagens and other compo-
nents of the extracellular matrix (ECM) (28). This reaction
is similar to the stromal reaction to a wound––indeed, tu-
mors have been likened to wounds, that do not heal (29).
 at Zentralbibliothek on January 18, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2015 11
Figure 4. Knockdown of PNKP or TDP1 leads to increase in expression of PSAT1 and PHGDH. Western blot analysis of XRCC1, PHGDH and PSAT1
expression upon KD of PNKP (A) or TDP1 (B). -Actin served as a loading control. (C) TDP1 mRNA levels after KD of TDP1, quantified by qPCR
and normalised to GAPDH.
Figure 5. Increased expression of serine biosynthesis pathway enzymes after XRCC1 knockdown. (A) mRNA levels of MTHFD2 after XRCC1 KD,
quantified by qPCR and normalised to GAPDH. Values are mean ± SD from four independent experiments. The P-value was calculated using Student’s
t-test. (B) Measurement of GSH levels in cells using fluorescence of Dibromobimane normalised to fluorescence of Hoechst 33342. Control or XRCC1
KD cells were seeded 24 h prior to measurement at the indicated densities into 24-well plates. Values are mean ± SD from three independent experiments
with four replicates each. The P-values were calculated using Student’s t-test.
Likewise, fibrosis is a process that can result from incorrect
wound-healing, and is associated with an excessive accumu-
lation of ECM proteins due to activation of a cascade of
pro-inflammatory events. Interestingly, our results showed
that XRCC1 KD leads to a proteomics profile much remi-
niscent of inflammatory events in hepatic fibrosis (Table 1,
rank 1). Detailed analysis of the involved proteins revealed
significant increases in the production of collagens as well
as tissue modulators, such as MMP2 and TIMP2 (Table 3,
white). Closely associated pathways involving similar pro-
teins (‘inhibition of matrix metalloproteases’, ‘intrinsic pro-
thrombin activation pathway’, ‘atherosclerosis signalling’,
‘heme degradation’, ‘basal cell carcinoma signalling’, ‘Il-
8 signalling’, ‘role of Wnt/GSK-3 signalling’ and ‘germ
cell-sertoli cell junction signalling’) were also deregulated
in XRCC1 KD cells (Tables 1 and 3, ‘tissue remodelling’).
These events suggested the establishment of a phenotype
of active ECM remodeling, a known feature of malignancy
(30), by cells that harbour genetic instability in form of per-
sistent SSBs. Modulation of the ECM is also an important
feature of the epithelial to mesenchymal transition (EMT)
that forms part of the invasion and metastasis hallmark of
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cancer (2). Consistent with the notion thatXRCC1KDcells
are modulating their intra- and extracellular morphology
(above), also an enhancement of EMT-associated proteins,
such as WNT5B, became evident in our dataset (Tables 1
and 3). Furthermore, many proteins associated with tis-
sue remodelling and cellular invasion (e.g. TIMP1, TIMP2)
were clearly deregulated in the dataset in a manner sug-
gesting a heightened state of cellular plasticity (e.g. ‘glioma
invasiveness signalling’) (Tables 1 and 3). An extension of
analysis to pathways beyond the ones ranking in the top 17
revealed a multitude of other proteins involved in cellular
motility and invasiveness, and associated with metastasis to
be significantly deregulated (Table 3, all proteins with white
background without associated pathway number in the last
column).
In conclusion, the data presented here shows that the
build-up of endogenous DNA lesions brought about by a
deficiency in BER capacity can provoke gene expression
changes that lead to changes in a variety of cellular path-
ways in primary cells very much reminiscent of changes that
are hallmarks of cancerous cells. Furthermore, our results
suggest that changes in the hallmarks of cellularmetabolism
as well as invasion andmetastasis are not late-onset adapta-
tions in cancer cells, but might be traits that are acquired at
an early time-point due to genetic instability. Therefore, we
find that a deficiency in BER can rewire cellular metabolism
toward a cancer-like phenotype even in the absence of ex-
ogenous DNA damage, thus underpinning the importance
of BER of endogenous DNA damage.
DISCUSSION
The DNA damage response, which is clearly detected to be
activated byXRCC1KD, activates many proteins including
transcription factors such as p53, E2F1 and Sp1 as well as
a subset of protein kinases, including ATM and AKT (re-
viewed in e.g. (4,31)). All these proteins induce a cascade
of changes that in turn will affect gene expression spectrum
bringing cellular metabolism in terms with a new intracel-
lular landscape caused by genetic instability. Importantly,
however, there is a crucial temporal difference between the
classical DNA damage response and the changes we ob-
serve upon XRCC1 KD. Classically, the canonical DNA
damage response is a mechanism to respond to acute DNA
damage and results in short-term adaptations in the cell,
which are reverted upon disappearance of the harmful stim-
ulus and repair of the damage. In contrast to this, XRCC1
KD cells are dealing with a long-term activation of the
DNA damage response (in this study, it was lasting for sev-
eral days). Thus, the changes we observe reflect long-term
adaptivemechanisms that are evoked by the inability of cells
to return to a basal, undisturbed state for long enough to
completely revert the activation of the damage response.We
hypothesise that this leads to an effect akin of ‘cellular ex-
haustion’, which ultimately results in the reprogramming of
cells gene expression. Notably, these changes are a ‘signa-
ture’ of genetic instability that can provoke cell transforma-
tion by generating new mutations, and this ‘signature’ pos-
sibly remains present even in cancer cells. This hypothesis is
in clear correlation with our detailed analysis of the data,
which demonstrated significant changes in the XRCC1 KD
cells toward a phenotype detected in cancer cells. Impor-
tantly, a big proportion of the significantly deregulated tar-
gets in our study have been reported as deregulated in a
similar manner in human cancers as well (Supplementary
Material, Supplementary Table S1). Interestingly, the only
targets clearly counter-regulated and thus inhibiting further
proliferation were the proteins associated with DNA repli-
cation itself, suggesting that the G1-S checkpoint was still a
functional brake protecting these cells from true malignant
transformation. Taken together, these results suggest that
XRCC1 knockdown causes pathway changes that correlate
strongly with a ‘cancer blueprint’.
Analysis of available epidemiological literature on can-
cer incidence and its associations with alterations in DNA
repair pathways support the involvement of BER, and in
particular XRCC1, in cancer risk. So far, most epidemio-
logical research concerning XRCC1 has been focusing on
the prevalence of polymorphisms, and possible links to can-
cer risk for carriers of certain polymorphic traits. Unfor-
tunately however, only an absolute minority of these stud-
ies have considered analysing the levels of XRCC1 pro-
tein in relation to these polymorphisms, which might be
a very important factor considering that XRCC1 has no
enzymatic activity but functions to coordinate the steady-
state levels and the activities of BER proteins as a molecu-
lar scaffold. Nevertheless, one study did show that a novel
polymorphism in XRCC1 gene reduced its promoter activ-
ity, thus leading to lower protein levels and increased risk
of non-small cell lung cancer (32). There are some stud-
ies however, which have directly addressed the expression
levels of XRCC1 in normal versus tumour tissue. Inter-
estingly, XRCC1 has been found to be downregulated in
a number of different tumors (33–35). Decreased expres-
sion was associated with higher proliferation (and thus in-
creased malignancy), as judged by Ki-67 staining (36), and
shorter overall survival (34). A dysregulation of XRCC1,
among a number of other targets, was found to be associ-
ated with higher prevalence of lung cancer (37). The rela-
tive expression of XRCC1 was significantly lower in periph-
eral blood mononuclear cells from esophageal squamous
cell carcinoma patients compared to the control group (38).
Additionally, CpG island hypermethylation of XRCC1 was
found to increase gradually throughout lung carcinogene-
sis in a chemical-induced rat carcinogenesis model. Also, a
decrease in XRCC1, and thus defective BER, seems to be
a contributing factor to the development of myeodysplas-
tic and myeloproliferative diseases (39). Similarly, lower ex-
pression levels of XRCC1 in bladder cancer tumour cells
were associated with worse survival after radiotherapy (40).
All of these observations support the conclusion from our
study, that a deficiency in BER can create a favourable con-
dition for malignant transformation of cells.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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